What is the recommended dose of polyethylene glycol 3350 for constipation, including alternative dosing for bisacodyl and sodium picosulfate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Recommended Dosing for Polyethylene Glycol 3350 and Alternatives

For chronic idiopathic constipation in adults, start polyethylene glycol 3350 at 17 grams once daily, bisacodyl at 5 mg daily (maximum 10 mg daily), and sodium picosulfate follows similar dosing to bisacodyl as a stimulant laxative. 1, 2

Polyethylene Glycol 3350 Dosing

Adult Dosing

  • Initial dose: 17 grams (approximately one heaping tablespoon) once daily 1, 2
  • Administration: Mix in 4-8 ounces of water, juice, soda, coffee, or tea 2
  • Time to effect: 2-4 days (48-96 hours) to produce first bowel movement 2
  • Titration: Adjust based on symptom response and side effects 1
  • Maximum dose: No clear maximum dose established 1
  • Duration of efficacy: Response has been shown to be durable over 6 months 1

The 2023 AGA-ACG guidelines consistently recommend 17 grams daily as the standard starting dose across all evidence sources, with demonstrated efficacy in achieving ≥3 complete spontaneous bowel movements per week in 42% of patients versus 13% with placebo over 24 weeks 3.

Pediatric Dosing

  • Children ≥17 years: Same as adult dosing (17 grams daily) 4
  • Children <24 months: 0.45-1.1 g/kg/day for PEG 3350 (evidence limited but safe) 5
  • Children with functional constipation: Starting dose of 0.4 g/kg/day is recommended based on controlled trials 6
  • Effective maintenance dose in children: Mean of 0.8-0.84 g/kg/day (range 0.27-1.42 g/kg/day) 7

Bisacodyl Dosing

  • Initial dose: 5 mg once daily 1
  • Maximum dose: 10 mg orally daily 1
  • Titration: Adjust per symptom response and side effects 1
  • Duration: Recommended for short-term use or rescue therapy only 1

Important caveat: Long-term safety and efficacy of bisacodyl are unknown, and prolonged or excessive use can cause diarrhea and electrolyte imbalance 1. This makes it less suitable than PEG 3350 for chronic management.

Sodium Picosulfate Dosing

  • Dosing: Similar to bisacodyl as both are stimulant laxatives 1
  • Bowel preparation context: 340 mL plus bisacodyl has been studied for colonoscopy preparation with good tolerability 8
  • Duration: Like bisacodyl, recommended for short-term use or rescue therapy 1

The guidelines group bisacodyl and picosulfate together with identical dosing recommendations and cautions about long-term use 1.

Common Side Effects and Management

PEG 3350

  • Bloating, abdominal discomfort, and cramping are most common 1
  • Side effects typically decrease markedly after the first week of treatment 3
  • Ensure adequate hydration during use 1
  • Significantly fewer side effects compared to lactulose (15 vs 23 patients with adverse events) 9

Bisacodyl/Picosulfate

  • Cramping and abdominal discomfort limit tolerability 1
  • Risk of diarrhea and electrolyte imbalance with prolonged use 1

Clinical Decision Algorithm

  1. First-line for chronic constipation: PEG 3350 17 grams daily 1

    • Cost-effective ($10-45/month vs $523-563 for prescription secretagogues) 1
    • Well-tolerated with durable response 1, 3
    • No clear maximum dose allows for upward titration if needed 1
  2. Short-term or rescue therapy: Bisacodyl 5-10 mg daily 1

    • Use when rapid effect needed
    • Avoid prolonged use due to unknown long-term safety 1
  3. Dose adjustment: Titrate PEG 3350 every 3 days based on achieving 2 soft stools per day 7

  4. Treatment duration: PEG 3350 achieves best results between 1-2 weeks, though can be used longer under physician guidance 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.